Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 3
2018 4
2019 4
2020 2
2021 4
2022 4
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Obesity Treatments to Improve Type 1 Diabetes (OTID): a randomized controlled trial of the combination of glucagon-like peptide 1 analogues and sodium-glucose cotransporter 2 inhibitors-protocol for Obesity Treatments to Improve Type 1 Diabetes (the OTID trial).
Al-Ozairi E, Narula K, Miras AD, Taghadom E, Samad AE, Al Kandari J, Alyosef A, Mashankar A, Al-Najim W, le Roux CW. Al-Ozairi E, et al. Among authors: al najim w. Trials. 2024 Feb 16;25(1):129. doi: 10.1186/s13063-024-07930-3. Trials. 2024. PMID: 38365744 Free PMC article.
Stratification of obesity phenotypes to optimize future therapy (SOPHIA).
Tahrani AA, Panova-Noeva M, Schloot NC, Hennige AM, Soderberg J, Nadglowski J, Tarasenko L, Ahmad NN, Sleypen BS, Bravo R, Al-Najim W, le Roux CW. Tahrani AA, et al. Among authors: al najim w. Expert Rev Gastroenterol Hepatol. 2023 Jul-Dec;17(10):1031-1039. doi: 10.1080/17474124.2023.2264783. Epub 2023 Oct 24. Expert Rev Gastroenterol Hepatol. 2023. PMID: 37791820 Review.
Food preferences after bariatric surgery: a review update.
Alabduljabbar K, Al-Najim W, le Roux CW. Alabduljabbar K, et al. Among authors: al najim w. Intern Emerg Med. 2023 Mar;18(2):351-358. doi: 10.1007/s11739-022-03157-9. Epub 2022 Dec 7. Intern Emerg Med. 2023. PMID: 36478323 Review.
Does Bypass of the Proximal Small Intestine Impact Food Intake, Preference, and Taste Function in Humans? An Experimental Medicine Study Using the Duodenal-Jejunal Bypass Liner.
Aldhwayan MM, Al-Najim W, Ruban A, Glaysher MA, Johnson B, Chhina N, Dimitriadis GK, Prechtl CG, Johnson NA, Byrne JP, Goldstone AP, Teare JP, Le Roux CW, Miras AD. Aldhwayan MM, et al. Among authors: al najim w. Nutrients. 2022 May 20;14(10):2141. doi: 10.3390/nu14102141. Nutrients. 2022. PMID: 35631283 Free PMC article. Clinical Trial.
Duodenal-Jejunal Bypass Liner for the management of Type 2 Diabetes Mellitus and Obesity: A Multicenter Randomized Controlled Trial.
Ruban A, Miras AD, Glaysher MA, Goldstone AP, Prechtl CG, Johnson N, Chhina N, Al-Najim W, Aldhwayan M, Klimowska-Nassar N, Smith C, Lord J, Li JV, Flores L, Al-Lababidi M, Dimitriadis GK, Patel M, Moore M, Chahal H, Ahmed AR, Cousins J, Aldubaikhi G, Glover B, Falaschetti E, Ashrafian H, Roux CWL, Darzi A, Byrne JP, Teare JP. Ruban A, et al. Among authors: al najim w. Ann Surg. 2022 Mar 1;275(3):440-447. doi: 10.1097/SLA.0000000000004980. Ann Surg. 2022. PMID: 34647708 Free PMC article. Clinical Trial.
Obesity and responsibility: Is it time to rethink agency?
Grannell A, Fallon F, Al-Najim W, le Roux C. Grannell A, et al. Among authors: al najim w. Obes Rev. 2021 Aug;22(8):e13270. doi: 10.1111/obr.13270. Epub 2021 May 12. Obes Rev. 2021. PMID: 33977636 Review.
Liraglutide Does Not Adversely Impact Fat-Free Mass Loss.
Grannell A, Martin WP, Dehestani B, Al-Najim W, Murphy JC, le Roux CW. Grannell A, et al. Among authors: al najim w. Obesity (Silver Spring). 2021 Mar;29(3):529-534. doi: 10.1002/oby.23098. Epub 2021 Feb 2. Obesity (Silver Spring). 2021. PMID: 33528919 Clinical Trial.
23 results